Together we laid the foundations of the Viromer chemistry, constructed the first library and quickly realized that this could be a success. Betatesters confirmed our findings and we did our first product roll-out in Jan 2013, 18 months after starting the company.
Meanwhile back in Halle we built our sales force and created a network of distributors now spanning the globe. Still, it was the tough times probably any small business goes through when creating and selling an innovation from scratch.
It was in summer 2014, when a German startup trusted us with their formulation development. We were thrilled to be back in the therapeutics game and our partner is now using the recipe in clinical trials. Good luck! We owe you guys.
So why not following up with Viromers in vivo? So we did with mRNA and it worked on the first try. And on the second again (so it was not an artefact). And in many other people‘s hands. We went for improvements, created our library 3 which gave phenomenal leads not only for mRNA, but also for all other major payloads, such as siRNA, pDNA, RNA replicons or Cas9 RNP.
More data are coming in and as we know from prior experience, this is only the beginning.
Lipocalyx is now looking forward to bring its technology to the next level, providing GMP grade materials and licenses to our partners.
Contact us and find out what we can do for you specifically.